Cargando…

DLAT is a promising prognostic marker and therapeutic target for hepatocellular carcinoma: a comprehensive study based on public databases

Cuproptosis is a new mechanism of cell death that differs from previously identified regulatory cell death mechanisms. Cuproptosis induction holds promise as a new tumour treatment. Therefore, we investigated the value of cuproptosis-related genes in the management of hepatocellular carcinoma (HCC)....

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Peng, Zhao, Jiang-Hua, Yuan, Liu-Xia, Ju, Lin-Ling, Wang, Hui-Xuan, Wang, Feng, Chen, Lin, Cai, Wei-Hua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10570290/ https://www.ncbi.nlm.nih.gov/pubmed/37828099 http://dx.doi.org/10.1038/s41598-023-43835-y

Ejemplares similares

A Novel Cuproptosis-Related Signature Identified DLAT as a Prognostic Biomarker for Hepatocellular Carcinoma Patients
por: Bai, Wen Dong, et al.
Publicado: (2022)

Comprehensive analysis identifies cuproptosis-related gene DLAT as a potential prognostic and immunological biomarker in pancreatic adenocarcinoma
por: Zhang, Xiaoling, et al.
Publicado: (2023)

Cuproptosis-related gene DLAT serves as a prognostic biomarker for immunotherapy in clear cell renal cell carcinoma: multi-database and experimental verification
por: Huang, Shuaishuai, et al.
Publicado: (2023)

Systematic pan-cancer analysis identifies cuproptosis-related gene DLAT as an immunological and prognostic biomarker
por: Xu, Lidong, et al.
Publicado: (2023)

MELK promotes HCC carcinogenesis through modulating cuproptosis-related gene DLAT-mediated mitochondrial function
por: Li, Zhipeng, et al.
Publicado: (2023)

PM2.5 promotes NSCLC carcinogenesis through translationally and transcriptionally activating DLAT-mediated glycolysis reprograming
por: Chen, Qianqian, et al.
Publicado: (2022)

Cuproptosis-Related Gene DLAT as a Novel Biomarker Correlated with Prognosis, Chemoresistance, and Immune Infiltration in Pancreatic Adenocarcinoma: A Preliminary Study Based on Bioinformatics Analysis
por: Fang, Zengli, et al.
Publicado: (2023)

The Multi-Partner Consortium to Expand Dementia Research in Latin America (ReDLat): Driving Multicentric Research and Implementation Science
por: Ibanez, Agustin, et al.
Publicado: (2021)

Roles of cuproptosis-related gene DLAT in various cancers: a bioinformatic analysis and preliminary verification on pro-survival autophagy
por: Yang, Qinjing, et al.
Publicado: (2023)

Methylation of S100A8 is a promising diagnosis and prognostic marker in hepatocellular carcinoma
por: Liu, Kun, et al.
Publicado: (2016)

Promising diagnostic and prognostic value of E2Fs in human hepatocellular carcinoma
por: Huang, Yan-Lin, et al.
Publicado: (2019)

DLC-1 is an independent prognostic marker and potential therapeutic target in hepatocellular cancer
por: Song, L. J., et al.
Publicado: (2016)

Sulfiredoxin‐1 is a promising novel prognostic biomarker for hepatocellular carcinoma
por: Rao, Qian‐Wen, et al.
Publicado: (2020)

SLC1A4: A Powerful Prognostic Marker and Promising Therapeutic Target for HCC
por: Peng, Xiaozhen, et al.
Publicado: (2021)

Identification of prognostic immune cells and potential immune-related markers in hepatocellular carcinoma
por: Mai, Jialuo, et al.
Publicado: (2022)

Comprehensive Analysis of HOX Family Members as Novel Diagnostic and Prognostic Markers for Hepatocellular Carcinoma
por: Jin, Zhipeng, et al.
Publicado: (2022)

Overexpression of non-SMC condensin I complex subunit G serves as a promising prognostic marker and therapeutic target for hepatocellular carcinoma
por: Liu, Wanwei, et al.
Publicado: (2017)

GIV is a promising novel poor prognostic factor in liver hepatocellular carcinoma
por: Zou, Zhenzhen, et al.
Publicado: (2022)

ZWINT is a Promising Therapeutic Biomarker Associated with the Immune Microenvironment of Hepatocellular Carcinoma
por: Lin, Tong, et al.
Publicado: (2021)

Comprehensive Characterization of the Genomic Landscape in Chinese Pulmonary Neuroendocrine Tumors Reveals Prognostic and Therapeutic Markers (CSWOG-1901)
por: Peng, Wenying, et al.
Publicado: (2022)

Comprehensive analysis of the prognostic value and functions of prefoldins in hepatocellular carcinoma
por: Ke, Shanjia, et al.
Publicado: (2022)

EPAC1 overexpression is a prognostic marker and its inhibition shows promising therapeutic potential for gastric cancer
por: Sun, Ding-Ping, et al.
Publicado: (2017)

Expression and function of myelin expression factor 2 in hepatocellular carcinoma
por: Zhang, Peng, et al.
Publicado: (2023)

Comprehensive analysis of an autophagy-related prognostic model for predicting survival based on TCGA and ICGC database in hepatocellular carcinoma patients
por: An, Li-Na, et al.
Publicado: (2022)

Comprehensive Analysis of the Prognostic Values of the TRIM Family in Hepatocellular Carcinoma
por: Dai, Weiyu, et al.
Publicado: (2021)

AURKB as a Promising Prognostic Biomarker in Hepatocellular Carcinoma
por: Xiao, Jingchuan, et al.
Publicado: (2021)

Comprehensive analysis to identify the neurotransmitter receptor-related genes as prognostic and therapeutic biomarkers in hepatocellular carcinoma
por: Wang, Xiaoqiang, et al.
Publicado: (2022)

IL-6/STAT3 Is a Promising Therapeutic Target for Hepatocellular Carcinoma
por: Xu, Junnv, et al.
Publicado: (2021)

Comprehensive proteomic signature and identification of CDKN2A as a promising prognostic biomarker and therapeutic target of colorectal cancer
por: Wang, Qian-Qian, et al.
Publicado: (2022)

Copeptin: a new and promising diagnostic and prognostic marker
por: Katan, Mira, et al.
Publicado: (2008)

Cancer stem cells in hepatocellular carcinoma: an overview and promising therapeutic strategies
por: Wang, Nuozhou, et al.
Publicado: (2018)

KCNK levels are prognostic and diagnostic markers for hepatocellular carcinoma
por: Li, Wen-Chao, et al.
Publicado: (2019)

DCK is a promising prognostic biomarker and correlated with immune infiltrates in hepatocellular carcinoma
por: Song, Danjun, et al.
Publicado: (2020)

Platelet‐to‐white blood cell ratio: A novel and promising prognostic marker for HBV‐associated decompensated cirrhosis
por: Zhang, JinFei, et al.
Publicado: (2020)

Promising Novel Biomarkers for Hepatocellular Carcinoma: Diagnostic and Prognostic Insights
por: Yu, James, et al.
Publicado: (2023)

CSTF2 Acts as a Prognostic Marker Correlated with Immune Infiltration in Hepatocellular Carcinoma
por: Zhang, Wang, et al.
Publicado: (2022)

Comprehensive analysis to identify DLEU2L/TAOK1 axis as a prognostic biomarker in hepatocellular carcinoma
por: Shi, Yi, et al.
Publicado: (2021)

Cancer Stem Cell Functions in Hepatocellular Carcinoma and Comprehensive Therapeutic Strategies
por: Liu, Yu-Chin, et al.
Publicado: (2020)

Comprehensive analysis reveals TSEN54 as a robust prognosis biomarker and promising immune-related therapeutic target for hepatocellular carcinoma
por: Fu, Bidong, et al.
Publicado: (2023)

Karonudib is a promising anticancer therapy in hepatocellular carcinoma
por: Hua, Xiangwei, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_69hg0m80jjon4q3v7s6ice0q75